Henry Schein (HSIC) is often treated like a plain distributor, which naturally pushes investors toward a low-margin, low-multiple view of the business. That misses an important part of the story. Henry Schein is better understood as a dental-and-practice-workflow platform that combines distribution, equipment, technical service, software, specialty products, and practice support inside office-based care. In the first quarter of 2026, net sales increased 6.3% to $3.4 billion, while adjusted EBITDA rose to $289 million from $259 million a year earlier and non-GAAP diluted EPS increased to $1.32 from $1.15. Those results matter because they show that the company is still extracting better economics from a broader service model than a simple wholesaler label implies.
Why dental specialization and workflow depth matter
Henry Schein’s moat starts with specialization in office-based care, especially dental. In its 2025 annual report, the company said dental made up 52.0% of net sales, including 36.6% from dental merchandise, 13.6% from dental equipment, and 1.8% from value-added services. That alone shows why the company should not be viewed as a generic broadline distributor.
Related Coverage
The dental focus also goes beyond shipping boxes. Henry Schein serves a fragmented provider base that ranges from solo practitioners to larger group practices and dental support organizations. That fragmentation favors vendors that can provide reliable fulfillment, equipment installation, repair, financing, education, and workflow support in one relationship. The company’s annual report says it stocks more than 300,000 products and operates 127 equipment sales and service centers worldwide, reinforcing the idea that physical presence and technical support matter.
The first-quarter 2026 results suggest the dental engine is still healthy. Global Dental Distribution merchandise sales increased 9.0%, with 3.0% internal sales growth, while Global Dental Distribution equipment sales increased 8.6%, with 3.5% internal sales growth. Those figures are useful because they indicate that both consumables and higher-ticket workflow categories were contributing.
How software, equipment, and value-added services change the earnings profile
The real reason Henry Schein deserves a different lens is that not all revenue is equally commodity-like. The company separates Global Distribution and Value-Added Services, Global Specialty Products, and Global Technology as distinct reportable segments. In first-quarter 2026, Global Distribution and Value-Added Services sales increased 6.1%, Global Specialty Products sales increased 8.1%, and Global Technology sales increased 7.0%, with Global Technology posting 6.9% internal sales growth.
That mix matters because software, equipment, and services can deepen customer relationships and improve economics. Henry Schein’s Global Technology segment includes practice management software, e-services, and other products distributed to health care providers. Its annual report also describes Henry Schein One as a business focused on practice management software, revenue cycle management, and patient relationship management solutions. Those tools push the company further into day-to-day practice operations.
Value-added services also matter more than the headline numbers suggest. The company includes financial services, continuing education, consulting, and other practice services inside its distribution-and-services segment. Equipment repair and installation are part of the offering too. When a vendor helps a practice choose equipment, install it, service it, finance it, and connect it to software workflows, the relationship looks much more like embedded infrastructure than a low-margin supply shipment.
What recent margin, cash-flow, and acquisition discipline say about execution
Recent results point to improving execution. In the first quarter, gross profit increased to $1.07 billion from $1.00 billion, while operating income rose to $182 million from $175 million despite continued restructuring and related costs. Management also said it is targeting more than $200 million of operating income improvement over the next few years, including a $125 million run-rate by year-end 2026.
Capital allocation remains active but measured. During the quarter, Henry Schein repurchased about 1.6 million shares at an average price of $77.64 for a total of $125 million, and it ended the quarter with $655 million still authorized for future repurchases. The company also acquired a controlling interest in its S.I.N. distributor in the U.S. to strengthen its position in the value implant market, which fits the broader pattern of using acquisitions to support category depth rather than chasing unrelated scale.
Cash flow was the weak spot in the quarter. Henry Schein reported net cash used in operating activities of $97 million, compared with net cash provided by operating activities of $37 million a year earlier. That is worth watching. Still, a single quarter does not fully define the story here, especially for a company carrying inventory, receivables, and integration activity across a complex distribution-and-services platform. The more important question is whether management continues converting growth into better gross margin, better EBITDA, and tighter operating discipline. So far, the first-quarter trajectory supports that view.
What investors may still be underestimating
The underappreciated point is that Henry Schein’s economic role inside dental practices is broader than product delivery. It sits across merchandise, equipment, specialty products, software, financing, consulting, and technical service. That makes the company more exposed to workflow depth and customer retention than the plain distributor label suggests.
Investors may also underestimate how much the business mix can evolve even if reported margins do not suddenly look like those of a pure software company. If technology, specialty products, value-added services, and equipment-related activity keep taking a larger strategic role, Henry Schein can improve the quality of earnings without needing to abandon its core distribution position. In other words, distribution may be the entry point, but workflow relevance is what can keep the model durable.
That is why the better lens for Henry Schein is a dental-and-practice platform with multiple ways to monetize the customer relationship. The market may still see a distributor. The business itself looks more like office-based care infrastructure.
Key Signals for Investors
Dental still represented 52.0% of 2025 net sales, but that mix includes equipment and value-added services alongside merchandise, underscoring the depth of the franchise.
First-quarter 2026 growth in dental merchandise, dental equipment, value-added services, and Global Technology suggests the company is participating across multiple workflow layers, not only supply distribution.
Gross profit, adjusted EBITDA, and buybacks all moved in the right direction in the quarter, even though operating cash flow was temporarily weak.
Sources
Henry Schein, Inc., earnings release furnished with Form 8-K, May 5, 2026. https://www.sec.gov/Archives/edgar/data/1000228/000100022826000021/exhibit991.htm
Henry Schein, Inc., Form 10-Q for the quarter ended March 28, 2026, filed May 5, 2026. https://www.sec.gov/Archives/edgar/data/1000228/000100022826000024/hsic-20260328.htm
Henry Schein, Inc., Form 10-K for the year ended December 27, 2025, filed February 24, 2026. https://www.sec.gov/Archives/edgar/data/1000228/000100022826000013/hsic-20251227.htm
-1024x683.jpg "Deep State Revenge? FBI Investigated Trump for Firing Comey")
